Publicaciones en las que colabora con Iván Peñuelas Sánchez (32)

2022

  1. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism

    Neurobiology of Disease, Vol. 167

  2. Performance evaluation of a preclinical SPECT/CT system for multi-animal and multi-isotope quantitative experiments

    Scientific Reports, Vol. 12, Núm. 1

2020

  1. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 8, pp. 1885-1912

  2. Proven validity and management impact of amyloid imaging in Alzheimer’s disease—repetita juvant

    European Journal of Nuclear Medicine and Molecular Imaging

2018

  1. Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality

    Physica Medica, Vol. 46, pp. 134-139

2017

  1. Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury

    Journal of Translational Medicine, Vol. 15, Núm. 1

2016

  1. Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency

    Human Molecular Genetics, Vol. 25, Núm. 7, pp. 1318-1327

2015

  1. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: A longitudinal in-vivo study

    Neurobiology of Disease, Vol. 77, pp. 165-172

  2. Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [18F]-tetrafluoroborate

    EJNMMI Research, Vol. 5, Núm. 1, pp. 1-9

2014

  1. In vivo monitoring of staphylococcus aureus biofilm infections and antimicrobial therapy by [18F] Fluoro-Deoxyglucose-MicroPET in a Mouse Model

    Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 11, pp. 6660-6667

  2. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway

    Neurobiology of Disease, Vol. 62, pp. 250-259

  3. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization

    Medical Physics, Vol. 41, Núm. 9

  4. Validación de técnicas de segmentación para la tomografía por emisión de positrones mediante imágenes ex-vivo de piezas quirúrgicas oncológicas

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 33, Núm. 2, pp. 79-86

2013

  1. Aportación del tiempo de vuelo y de la modelización de la respuesta a una fuente puntual a las características de funcionamiento del tomógrafo PET/TAC Biograph mCT

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 32, Núm. 1, pp. 13-21

  2. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 9, pp. 1394-1405

  3. Impact of time-of-flight and point-spread-function in SUV quantification for oncological PET

    Clinical Nuclear Medicine, Vol. 38, Núm. 2, pp. 103-109

2012

  1. Decreased carbon-11-flumazenil binding in early Alzheimer's disease

    Brain, Vol. 135, Núm. 9, pp. 2817-2825

  2. Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: Patterns of integration in therapy planning

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Núm. 5, pp. 771-781

  3. Twelve automated thresholding methods for segmentation of PET images: A phantom study

    Physics in Medicine and Biology, Vol. 57, Núm. 12, pp. 3963-3980

2011

  1. Dual time point 18F-FDOPA PET as a tool for characterizing brain tumors

    Revista Espanola de Medicina Nuclear, Vol. 30, Núm. 2, pp. 88-93